Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-masked exploratory Phase 2 trial of mapracorat ophthalmic suspension in dry eye syndrome
2010-018441-61Phase 2Completed
- Sponsor
- Dr Gerhard Mann
- Start
- Aug 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mapracorat in dry eye syndrome (DED) (5 arms), sponsored by Dr Gerhard Mann. Primary endpoint: Primary Safety Endpoint. Started Aug 2010; status: completed.
02
Drugs
mapracorat
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2010-018441-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018441-61.